Redmile Group, LLC Diversified Active

Name: Redmile Group, LLC Q2 2026 13F Filing | 13F Explorer
Creator: Redmile Group, LLC
Published: 2026-08-14

Location: Larkspur, CA

CIK: 0001425738 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $1.49B (100.0% shares, 0.0% debt)

Holdings (39)

New Positions (4)

CLYM CLIMB BIO INC 1.1%

Value $15.99M Shares 1,226,330 Share Price $13.04 Est. Cost/Share — Unrealized @ Report Date —

AURA AURA BIOSCIENCES INC 0.8%

Value $11.83M Shares 1,666,667 Share Price $7.10 Est. Cost/Share — Unrealized @ Report Date —

ODTX ODYSSEY THERAPEUTICS INC 0.5%

Value $7.952M Shares 425,000 Share Price $18.71 Est. Cost/Share — Unrealized @ Report Date —

INSM INSMED INC 0.4%

Value $5.463M Shares 51,234 Share Price $106.62 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
CLYM	CLIMB BIO INC	1,226,330	$15.99M	1.1%	$13.04	—	—	COM	28658R106
AURA	AURA BIOSCIENCES INC	1,666,667	$11.83M	0.8%	$7.10	—	—	COM	05153U107
ODTX	ODYSSEY THERAPEUTICS INC	425,000	$7.952M	0.5%	$18.71	—	—	COMMON STOCK	67613T104
INSM	INSMED INC	51,234	$5.463M	0.4%	$106.62	—	—	COM PAR $.01	457669307

Increased Positions (5)

AGMB AGOMAB THERAPEUTICS NV 2.4%

Value $35.49M (+2065.0%) Shares 2,733,926 (+1649.7%) Share Price $12.98 Est. Cost/Share — Unrealized @ Report Date —

STTK SHATTUCK LABS INC 3.2%

Value $47.83M (+34.3%) Shares 6,892,033 (+24.4%) Share Price $6.94 Est. Cost/Share — Unrealized @ Report Date —

CLDX CELLDEX THERAPEUTICS INC NEW 1.1%

Value $16.15M (+94.6%) Shares 433,921 (+65.9%) Share Price $37.21 Est. Cost/Share — Unrealized @ Report Date —

IDYA IDEAYA BIOSCIENCES INC 1.6%

Value $23.86M (+37.4%) Shares 640,202 (+22.9%) Share Price $37.27 Est. Cost/Share — Unrealized @ Report Date —

BMRN BIOMARIN PHARMACEUTICAL INC 1.0%

Value $15.17M (+54.5%) Shares 265,169 (+52.5%) Share Price $57.22 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
AGMB	AGOMAB THERAPEUTICS NV	2,733,926 (+1649.7%)	$35.49M (+2065.0%)	2.4%	$12.98	—	—	SPONSORED ADS	00860C102
STTK	SHATTUCK LABS INC	6,892,033 (+24.4%)	$47.83M (+34.3%)	3.2%	$6.94	—	—	COM	82024L103
CLDX	CELLDEX THERAPEUTICS INC NEW	433,921 (+65.9%)	$16.15M (+94.6%)	1.1%	$37.21	—	—	COM NEW	15117B202
IDYA	IDEAYA BIOSCIENCES INC	640,202 (+22.9%)	$23.86M (+37.4%)	1.6%	$37.27	—	—	COM	45166A102
BMRN	BIOMARIN PHARMACEUTICAL INC	265,169 (+52.5%)	$15.17M (+54.5%)	1.0%	$57.22	—	—	COM	09061G101

Decreased Positions (23)

SRRK SCHOLAR ROCK HLDG CORP 15.9%

Value $237M (-46.8%) Shares 4,311,092 (-52.5%) Share Price $55.00 Est. Cost/Share — Unrealized @ Report Date —

KRYS KRYSTAL BIOTECH INC 15.8%

Value $235M (+35.0%) Shares 632,005 (-6.2%) Share Price $371.67 Est. Cost/Share — Unrealized @ Report Date —

ABSI ABSCI CORPORATION 5.2%

Value $78.11M (+215.5%) Shares 6,739,675 (-18.3%) Share Price $11.59 Est. Cost/Share — Unrealized @ Report Date —

ADCT ADC THERAPEUTICS SA 0.8%

Value $12.33M (-78.7%) Shares 11,526,710 (-25.5%) Share Price $1.07 Est. Cost/Share — Unrealized @ Report Date —

NRIX NURIX THERAPEUTICS INC 6.6%

Value $98.83M (-17.5%) Shares 4,073,787 (-47.3%) Share Price $24.26 Est. Cost/Share — Unrealized @ Report Date —

IMNM IMMUNOME INC 7.0%

Value $104M (-14.4%) Shares 4,911,590 (-11.6%) Share Price $21.19 Est. Cost/Share — Unrealized @ Report Date —

NGNE NEUROGENE INC 3.0%

Value $44.41M (+50.9%) Shares 1,412,199 (-3.2%) Share Price $31.45 Est. Cost/Share — Unrealized @ Report Date —

ANNX ANNEXON INC 4.6%

Value $67.78M (-15.9%) Shares 11,869,877 (-18.4%) Share Price $5.71 Est. Cost/Share — Unrealized @ Report Date —

BEAM BEAM THERAPEUTICS INC 2.7%

Value $39.96M (+35.5%) Shares 1,164,259 (-5.9%) Share Price $34.32 Est. Cost/Share — Unrealized @ Report Date —

COGT COGENT BIOSCIENCES INC 1.3%

Value $19.48M (-26.4%) Shares 503,321 (-26.8%) Share Price $38.70 Est. Cost/Share — Unrealized @ Report Date —

STOK STOKE THERAPEUTICS INC 8.7%

Value $129M (-4.8%) Shares 3,945,920 (-5.2%) Share Price $32.72 Est. Cost/Share — Unrealized @ Report Date —

SLDB SOLID BIOSCIENCES INC 1.3%

Value $19.47M (+34.4%) Shares 1,948,695 (-3.1%) Share Price $9.99 Est. Cost/Share — Unrealized @ Report Date —

NUVB NUVATION BIO INC 1.2%

Value $17.22M (+27.3%) Shares 3,031,009 (-3.9%) Share Price $5.68 Est. Cost/Share — Unrealized @ Report Date —

DBVT DBV TECHNOLOGIES S A 0.5%

Value $6.731M (-34.4%) Shares 410,440 (-16.5%) Share Price $16.40 Est. Cost/Share — Unrealized @ Report Date —

ESTA ESTABLISHMENT LABS HLDGS INC 0.5%

Value $7.634M (+29.9%) Shares 88,964 (-14.0%) Share Price $85.81 Est. Cost/Share — Unrealized @ Report Date —

XENE XENON PHARMACEUTICALS INC 0.9%

Value $13.85M (-9.4%) Shares 229,374 (-12.7%) Share Price $60.36 Est. Cost/Share — Unrealized @ Report Date —

ORIC ORIC PHARMACEUTICALS INC 0.3%

Value $3.921M (-25.6%) Shares 362,010 (-12.9%) Share Price $10.83 Est. Cost/Share — Unrealized @ Report Date —

IVVD INVIVYD INC 0.2%

Value $2.266M (-34.2%) Shares 2,597,759 (-1.9%) Share Price $0.87 Est. Cost/Share — Unrealized @ Report Date —

ARDX ARDELYX INC 0.2%

Value $3.273M (-25.5%) Shares 641,750 (-12.5%) Share Price $5.10 Est. Cost/Share — Unrealized @ Report Date —

EPRX EUPRAXIA PHARMACEUTICALS INC 0.3%

Value $4.041M (-20.3%) Shares 611,400 (-12.7%) Share Price $6.61 Est. Cost/Share — Unrealized @ Report Date —

LIVN LIVANOVA PLC 0.5%

Value $7.66M (+11.2%) Shares 93,154 (-14.0%) Share Price $82.23 Est. Cost/Share — Unrealized @ Report Date —

ALXO ALX ONCOLOGY HLDGS INC 1.0%

Value $15.3M (-4.2%) Shares 7,392,504 (-7.2%) Share Price $2.07 Est. Cost/Share — Unrealized @ Report Date —

PRME PRIME MEDICINE INC 0.3%

Value $5.128M (-7.4%) Shares 1,389,632 (-12.6%) Share Price $3.69 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
SRRK	SCHOLAR ROCK HLDG CORP	4,311,092 (-52.5%)	$237M (-46.8%)	15.9%	$55.00	—	—	COM	80706P103
KRYS	KRYSTAL BIOTECH INC	632,005 (-6.2%)	$235M (+35.0%)	15.8%	$371.67	—	—	COM	501147102
ABSI	ABSCI CORPORATION	6,739,675 (-18.3%)	$78.11M (+215.5%)	5.2%	$11.59	—	—	COM	00091E109
ADCT	ADC THERAPEUTICS SA	11,526,710 (-25.5%)	$12.33M (-78.7%)	0.8%	$1.07	—	—	SHS	H0036K147
NRIX	NURIX THERAPEUTICS INC	4,073,787 (-47.3%)	$98.83M (-17.5%)	6.6%	$24.26	—	—	COM	67080M103
IMNM	IMMUNOME INC	4,911,590 (-11.6%)	$104M (-14.4%)	7.0%	$21.19	—	—	COM	45257U108
NGNE	NEUROGENE INC	1,412,199 (-3.2%)	$44.41M (+50.9%)	3.0%	$31.45	—	—	COM	64135M105
ANNX	ANNEXON INC	11,869,877 (-18.4%)	$67.78M (-15.9%)	4.6%	$5.71	—	—	COM	03589W102
BEAM	BEAM THERAPEUTICS INC	1,164,259 (-5.9%)	$39.96M (+35.5%)	2.7%	$34.32	—	—	COM	07373V105
COGT	COGENT BIOSCIENCES INC	503,321 (-26.8%)	$19.48M (-26.4%)	1.3%	$38.70	—	—	COM	19240Q201
STOK	STOKE THERAPEUTICS INC	3,945,920 (-5.2%)	$129M (-4.8%)	8.7%	$32.72	—	—	COM	86150R107
SLDB	SOLID BIOSCIENCES INC	1,948,695 (-3.1%)	$19.47M (+34.4%)	1.3%	$9.99	—	—	COM NEW	83422E204
NUVB	NUVATION BIO INC	3,031,009 (-3.9%)	$17.22M (+27.3%)	1.2%	$5.68	—	—	COM CL A	67080N101
DBVT	DBV TECHNOLOGIES S A	410,440 (-16.5%)	$6.731M (-34.4%)	0.5%	$16.40	—	—	SPONSORED ADS	23306J309
ESTA	ESTABLISHMENT LABS HLDGS INC	88,964 (-14.0%)	$7.634M (+29.9%)	0.5%	$85.81	—	—	COM	G31249108
XENE	XENON PHARMACEUTICALS INC	229,374 (-12.7%)	$13.85M (-9.4%)	0.9%	$60.36	—	—	COM	98420N105
ORIC	ORIC PHARMACEUTICALS INC	362,010 (-12.9%)	$3.921M (-25.6%)	0.3%	$10.83	—	—	COM	68622P109
IVVD	INVIVYD INC	2,597,759 (-1.9%)	$2.266M (-34.2%)	0.2%	$0.87	—	—	COM	00534A102
ARDX	ARDELYX INC	641,750 (-12.5%)	$3.273M (-25.5%)	0.2%	$5.10	—	—	COM	039697107
EPRX	EUPRAXIA PHARMACEUTICALS INC	611,400 (-12.7%)	$4.041M (-20.3%)	0.3%	$6.61	—	—	COM	29842P105
LIVN	LIVANOVA PLC	93,154 (-14.0%)	$7.66M (+11.2%)	0.5%	$82.23	—	—	SHS	G5509L101
ALXO	ALX ONCOLOGY HLDGS INC	7,392,504 (-7.2%)	$15.3M (-4.2%)	1.0%	$2.07	—	—	COM	00166B105
PRME	PRIME MEDICINE INC	1,389,632 (-12.6%)	$5.128M (-7.4%)	0.3%	$3.69	—	—	COM	74168J101

Unchanged Positions (7)

FATE FATE THERAPEUTICS INC 2.3%

Value $34.76M Shares 12,872,946 Share Price $2.70 Est. Cost/Share — Unrealized @ Report Date —

RGNX REGENXBIO INC 3.5%

Value $52.34M Shares 4,368,804 Share Price $11.98 Est. Cost/Share — Unrealized @ Report Date —

SLN SILENCE THERAPEUTICS PLC 1.6%

Value $23.77M Shares 2,164,777 Share Price $10.98 Est. Cost/Share — Unrealized @ Report Date —

ATRA ATARA BIOTHERAPEUTICS INC 0.3%

Value $5.071M Shares 441,701 Share Price $11.48 Est. Cost/Share — Unrealized @ Report Date —

ZYME ZYMEWORKS INC 0.9%

Value $12.85M Shares 491,654 Share Price $26.14 Est. Cost/Share — Unrealized @ Report Date —

CBLL CERIBELL INC 0.5%

Value $7.523M Shares 386,786 Share Price $19.45 Est. Cost/Share — Unrealized @ Report Date —

PLRX PLIANT THERAPEUTICS INC 0.1%

Value $880K Shares 772,126 Share Price $1.14 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
FATE	FATE THERAPEUTICS INC	12,872,946	$34.76M	2.3%	$2.70	—	—	COM	31189P102
RGNX	REGENXBIO INC	4,368,804	$52.34M	3.5%	$11.98	—	—	COM	75901B107
SLN	SILENCE THERAPEUTICS PLC	2,164,777	$23.77M	1.6%	$10.98	—	—	ADS	82686Q101
ATRA	ATARA BIOTHERAPEUTICS INC	441,701	$5.071M	0.3%	$11.48	—	—	COM NEW	046513206
ZYME	ZYMEWORKS INC	491,654	$12.85M	0.9%	$26.14	—	—	COM	98985Y108
CBLL	CERIBELL INC	386,786	$7.523M	0.5%	$19.45	—	—	COM	15678C102
PLRX	PLIANT THERAPEUTICS INC	772,126	$880K	0.1%	$1.14	—	—	COM	729139105